That BRAF V600E‐mutation analysis significantly increased the frequency of detected PTCs in the palpation‐guided group as compared to PTCs identified by Bethesda classification alone may be explained by the fact that the method used is very sensitive and can detect the mutation in only a few cancer cells. This evidence concerns the gene BRAF and cancer.